A current assessment of endoluminal approaches to the treatment of gastroesophageal reflux disease

Giuseppe Portale, Charles Filipi, Jeffrey H. Peters

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Over the past decade, a number of endoscopic techniques have been developed as alternatives to medical and surgical treatment of gastroesophageal ref lux disease (GERD). The driving force was to provide an outpatient transoral, endoscopic procedure effective in controlling reflux in a portion of patients with GERD. Three major technologies emerged, although each use different approaches to augment the barrier function of the lower esophageal sphincter, mechanisms may be similar. These include Endocinch which tightens the gastroesophageal junction via a set of suture plications around the lower esophageal sphincter, Stretta, which delivers radiofrequency energy at the cardia, and Enteryx, which is an inert polymer injected into the muscle layer of the gastroesophageal junction. To date, the underlying mechanism of action of these procedures has not been completely elucidated, although each alters the compliance of the GEJ and thus its ability to respond to a "refluxogenic stress". The target population currently consists of proton pump inhibitor-dependent GERD patients, with little or no hiatal hernia and without severe esophagitis or Barrett's. The Stretta procedure is the only procedure to date to be subjected to a sham-controlled trial. Registries of complications suggest that these techniques are relatively safe, but serious morbidity including rare mortality have been reported. All can be performed on an outpatient basis. Future comparative studies with predetermined end points, validated outcome measures, prolonged follow-up, and complete complication registries are needed to determine the role of endoscopic procedures in the clinical practice of patients with GERD. Evolution of the current technologies will almost certainly occur, and a commonly performed, efficacious endoscopic antireflux procedure is likely to emerge.

Original languageEnglish
Pages (from-to)225-234
Number of pages10
JournalSurgical Innovation
Volume11
Issue number4
DOIs
StatePublished - Dec 2004

Fingerprint

Gastroesophageal Reflux
Esophagogastric Junction
Lower Esophageal Sphincter
Registries
Outpatients
Therapeutics
Technology
Cardia
Hiatal Hernia
Esophagitis
Proton Pump Inhibitors
Health Services Needs and Demand
Sutures
Compliance
Polymers
Outcome Assessment (Health Care)
Morbidity
Muscles
Mortality

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

A current assessment of endoluminal approaches to the treatment of gastroesophageal reflux disease. / Portale, Giuseppe; Filipi, Charles; Peters, Jeffrey H.

In: Surgical Innovation, Vol. 11, No. 4, 12.2004, p. 225-234.

Research output: Contribution to journalArticle

@article{91f82a82a7d04915942fbc0903318348,
title = "A current assessment of endoluminal approaches to the treatment of gastroesophageal reflux disease",
abstract = "Over the past decade, a number of endoscopic techniques have been developed as alternatives to medical and surgical treatment of gastroesophageal ref lux disease (GERD). The driving force was to provide an outpatient transoral, endoscopic procedure effective in controlling reflux in a portion of patients with GERD. Three major technologies emerged, although each use different approaches to augment the barrier function of the lower esophageal sphincter, mechanisms may be similar. These include Endocinch which tightens the gastroesophageal junction via a set of suture plications around the lower esophageal sphincter, Stretta, which delivers radiofrequency energy at the cardia, and Enteryx, which is an inert polymer injected into the muscle layer of the gastroesophageal junction. To date, the underlying mechanism of action of these procedures has not been completely elucidated, although each alters the compliance of the GEJ and thus its ability to respond to a {"}refluxogenic stress{"}. The target population currently consists of proton pump inhibitor-dependent GERD patients, with little or no hiatal hernia and without severe esophagitis or Barrett's. The Stretta procedure is the only procedure to date to be subjected to a sham-controlled trial. Registries of complications suggest that these techniques are relatively safe, but serious morbidity including rare mortality have been reported. All can be performed on an outpatient basis. Future comparative studies with predetermined end points, validated outcome measures, prolonged follow-up, and complete complication registries are needed to determine the role of endoscopic procedures in the clinical practice of patients with GERD. Evolution of the current technologies will almost certainly occur, and a commonly performed, efficacious endoscopic antireflux procedure is likely to emerge.",
author = "Giuseppe Portale and Charles Filipi and Peters, {Jeffrey H.}",
year = "2004",
month = "12",
doi = "10.1177/155335060401100405",
language = "English",
volume = "11",
pages = "225--234",
journal = "Surgical Innovation",
issn = "1553-3506",
publisher = "SAGE Publications Inc.",
number = "4",

}

TY - JOUR

T1 - A current assessment of endoluminal approaches to the treatment of gastroesophageal reflux disease

AU - Portale, Giuseppe

AU - Filipi, Charles

AU - Peters, Jeffrey H.

PY - 2004/12

Y1 - 2004/12

N2 - Over the past decade, a number of endoscopic techniques have been developed as alternatives to medical and surgical treatment of gastroesophageal ref lux disease (GERD). The driving force was to provide an outpatient transoral, endoscopic procedure effective in controlling reflux in a portion of patients with GERD. Three major technologies emerged, although each use different approaches to augment the barrier function of the lower esophageal sphincter, mechanisms may be similar. These include Endocinch which tightens the gastroesophageal junction via a set of suture plications around the lower esophageal sphincter, Stretta, which delivers radiofrequency energy at the cardia, and Enteryx, which is an inert polymer injected into the muscle layer of the gastroesophageal junction. To date, the underlying mechanism of action of these procedures has not been completely elucidated, although each alters the compliance of the GEJ and thus its ability to respond to a "refluxogenic stress". The target population currently consists of proton pump inhibitor-dependent GERD patients, with little or no hiatal hernia and without severe esophagitis or Barrett's. The Stretta procedure is the only procedure to date to be subjected to a sham-controlled trial. Registries of complications suggest that these techniques are relatively safe, but serious morbidity including rare mortality have been reported. All can be performed on an outpatient basis. Future comparative studies with predetermined end points, validated outcome measures, prolonged follow-up, and complete complication registries are needed to determine the role of endoscopic procedures in the clinical practice of patients with GERD. Evolution of the current technologies will almost certainly occur, and a commonly performed, efficacious endoscopic antireflux procedure is likely to emerge.

AB - Over the past decade, a number of endoscopic techniques have been developed as alternatives to medical and surgical treatment of gastroesophageal ref lux disease (GERD). The driving force was to provide an outpatient transoral, endoscopic procedure effective in controlling reflux in a portion of patients with GERD. Three major technologies emerged, although each use different approaches to augment the barrier function of the lower esophageal sphincter, mechanisms may be similar. These include Endocinch which tightens the gastroesophageal junction via a set of suture plications around the lower esophageal sphincter, Stretta, which delivers radiofrequency energy at the cardia, and Enteryx, which is an inert polymer injected into the muscle layer of the gastroesophageal junction. To date, the underlying mechanism of action of these procedures has not been completely elucidated, although each alters the compliance of the GEJ and thus its ability to respond to a "refluxogenic stress". The target population currently consists of proton pump inhibitor-dependent GERD patients, with little or no hiatal hernia and without severe esophagitis or Barrett's. The Stretta procedure is the only procedure to date to be subjected to a sham-controlled trial. Registries of complications suggest that these techniques are relatively safe, but serious morbidity including rare mortality have been reported. All can be performed on an outpatient basis. Future comparative studies with predetermined end points, validated outcome measures, prolonged follow-up, and complete complication registries are needed to determine the role of endoscopic procedures in the clinical practice of patients with GERD. Evolution of the current technologies will almost certainly occur, and a commonly performed, efficacious endoscopic antireflux procedure is likely to emerge.

UR - http://www.scopus.com/inward/record.url?scp=16844383769&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16844383769&partnerID=8YFLogxK

U2 - 10.1177/155335060401100405

DO - 10.1177/155335060401100405

M3 - Article

VL - 11

SP - 225

EP - 234

JO - Surgical Innovation

JF - Surgical Innovation

SN - 1553-3506

IS - 4

ER -